Otonomy to Present at Cantor Fitzgerald Global Healthcare Conference
September 25 2018 - 4:05PM
Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company
dedicated to the development of innovative therapeutics for
otology, today announced that David A. Weber, Ph.D., president and
chief executive officer, will present at the 2018 Cantor Fitzgerald
Global Healthcare Conference on Tuesday, October 2, 2018 at 8:35
a.m. ET (5:35 a.m. PT) at the InterContinental New York Barclay
Hotel in New York City.
A live audio webcast of the presentation will be available
through the Events and Presentations page of the company's website
(www.otonomy.com).
About OtonomyOtonomy is a biopharmaceutical
company dedicated to the development of innovative therapeutics for
otology. The company pioneered the application of drug delivery
technology to the ear in order to develop products that achieve
sustained drug exposure from a single local administration. This
approach is covered by a broad patent estate and is being utilized
to develop a pipeline of products addressing important unmet
medical needs including Ménière’s disease, hearing loss, and
tinnitus. For additional information please visit
www.otonomy.com.
Contacts: Investor InquiriesWestwicke
PartnersRobert H. UhlManaging
Director858.356.5932robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From May 2024 to Jun 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jun 2023 to Jun 2024